Multiomics Market Report 2026

Multiomics Market Overview

• Multiomics market size has reached to $3.85 billion in 2025 • Expected to grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.6% • Growth Driver: Rising Demand For Personalized Medicine Fuels Growth Of The Multiomics Market • Market Trend: Innovative Single-Cell Multiomics Platforms Transforming Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Multiomics Market?

Multiomics refers to the integration and analysis of multiple omics data types, such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics to provide a more comprehensive understanding of biological systems. This technique improves understanding of complex diseases, biomarker identification, and precision medicine. The main types of multiomics are single-cell multiomics and bulk multiomics. Single-cell multiomics involves analyzing multiple types of biological molecules, such as DNA, RNA, proteins, and metabolites, within individual cells. It provides various platforms, such as genomics, transcriptomics, proteomics, metabolomics, and integrated omics platforms for several applications, including diagnostics, drug discovery and development, personalized medicine, agrigenomics, and others. These are used by several end users, such as academics and research organizations, pharmaceutical and biotechnology companies, clinical research organizations, and others.

What Is The Multiomics Market Growth Forecast?

The multiomics market size is expected to see rapid growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to advancements in multiomics platforms, rising demand for personalized medicine, increased integration of ai-based analytics, growing use of metabolomics in clinical settings, expanding multiomics applications in precision agriculture. Major trends in the forecast period include growing adoption of single-cell multiomics, rising integration of multi-layer biological data, increased use of multiomics in early disease diagnostics, expansion of multiomics in drug discovery pipelines, growing application of multiomics in agricultural genomics.

Global Multiomics Market Segmentation

1) By Type: Single-Cell Multiomics, Bulk Multiomics 2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms 3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications 4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users Subsegments: 1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics 2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

What Is The Driver Of The Multiomics Market?

The rising demand for personalized medicine is expected to propel the growth of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is rising due to technological advancements, increasing demand for targeted therapies, and global healthcare improvements. Multiomics helps personalized medicine by providing a detailed understanding of an individual's genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on the specific characteristics of each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the multiomics industry.

Key Players In The Global Multiomics Market

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Global Multiomics Market Trends and Insights

Major companies operating in the multiomics market are developing advanced single-cell multiomics platforms to enable scientists to run large-scale studies without sacrificing sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, allowing users to seamlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system enables scientists to isolate, barcode, and analyze single cells at a high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, offering flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, enhancing researchers' ability to gain more insights in less time.

What Are Latest Mergers And Acquisitions In The Multiomics Market?

In July 2024, Anacura, a Belgium-based provider of medical and pharmaceutical analytical services, acquired OHMX.bio for an undisclosed amount. With this acquisition, Anacura aimed to enhance its technological capabilities in multi-omics to strengthen its drug-discovery and diagnostics platform. OHMX.bio is a Belgium-based Ghent University spin-off specializing in advanced “-omics” technologies combining next-generation sequencing, bioinformatics, and multi-omic analyses to accelerate biologics and advanced therapy development (e.g., mRNA vaccines and CAR-T cells).

Regional Outlook

North America was the largest region in the multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Multiomics Market?

The multiomics market consists of revenues earned by entities by providing services such as experimental design, sample preparation, data analysis, and data generation. The market value includes the value of related goods sold by the service provider or included within the service offering. The multiomics market also includes sales of instruments, consumables and reagents, microarrays, bioinformatics workstations and servers, and imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Multiomics Market Report 2026?

The multiomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the multiomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.